FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ronald van Rij

Research Profile

Living Beings

HIV-1

Chemicals & Drugs

Disorders

Anatomy

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Nico Kloosterboer; Paul H P Groeneveld; Christine A Jansen; Teun J K van der Vorst; Fransje Koning; Carel N Winkel; Ashley J Duits; Frank Miedema; Debbie Van Baarle; Ronald P van Rij; Kees Brinkman; Hanneke Schuitemaker
Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
Evelien H B Stalmeijer; Ronald P van Rij; Brigitte Boeser-Nunnink; Janny A Visser; Marloes A Naarding; Dominique Schols; Hanneke Schuitemaker
In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists.
Ronald P van Rij; Michael Worobey; Janny A Visser; Hanneke Schuitemaker
Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ronald van Rij (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Nico Kloosterboer; Paul H P Groeneveld; Christine A Jansen; Teun J K van der Vorst; Fransje Koning; Carel N Winkel; Ashley J Duits; Frank Miedema; Debbie Van Baarle; Ronald P van Rij; Kees Brinkman; Hanneke Schuitemaker
Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
Virology 2005;339(1):70-80.
2004: Evelien H B Stalmeijer; Ronald P van Rij; Brigitte Boeser-Nunnink; Janny A Visser; Marloes A Naarding; Dominique Schols; Hanneke Schuitemaker
In vivo evolution of X4 human immunodeficiency virus type 1 variants in the natural course of infection coincides with decreasing sensitivity to CXCR4 antagonists.
Journal of virology 2004;78(6):2722-8.
2003: Ronald P van Rij; Michael Worobey; Janny A Visser; Hanneke Schuitemaker
Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination.
Virology 2003;314(1):451-9.
2003: David Kwa; Ronald P van Rij; Brigitte Boeser-Nunnink; Jose Vingerhoed; Hanneke Schuitemaker
Association between an interleukin-4 promoter polymorphism and the acquisition of CXCR4 using HIV-1 variants.
AIDS (London, England) 2003;17(7):981-5.
2003: Ronald P van Rij; Mette D Hazenberg; Birgit H B van Benthem; Sigrid A Otto; Maria Prins; Frank Miedema; Hanneke Schuitemaker
Early viral load and CD4+ T cell count, but not percentage of CCR5+ or CXCR4+ CD4+ T cells, are associated with R5-to-X4 HIV type 1 virus evolution.
AIDS research and human retroviruses 2003;19(5):389-98.
2003: Sanjay U C Sankatsing; Rieneke van Praag; Ronald P van Rij; Ronald Rientsma; Suzanne Jurriaans; Joep M A Lange; Jan M Prins; Hanneke Schuitemaker
Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
Antiviral therapy 2003;8(2):137-42.
2002: Miles P Davenport; John J Zaunders; Mette D Hazenberg; Hanneke Schuitemaker; Ronald P van Rij
Cell turnover and cell tropism in HIV-1 infection.
Trends in microbiology 2002;10(6):275-8.
2002: Ronald P van Rij; Rieneke van Praag; Jan M Prins; Ronald Rientsma; Suzanne Jurriaans; Joep M A Lange; Hanneke Schuitemaker
Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen.
Antiviral therapy 2002;7(1):37-41.
2002: Ronald P van Rij; Janny A Visser; Rieneke van Praag; Ronald Rientsma; Jan M Prins; Joep M A Lange; Hanneke Schuitemaker
Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
Journal of virology 2002;76(6):3054-8.
2002: Ronald P van Rij; Hanneke Schuitemaker
Host genetic factors in the clinical course of HIV-1 infection: chemokines and chemokine receptors.
Community genetics 2002;5(2):88-101.
2000: Ronald P van Rij; H Blaak; Janny A Visser; Mieke C Brouwer; Ronald Rientsma; SM Broersen; Ana Maria de Roda Husman; Hanneke Schuitemaker
Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1.
The Journal of clinical investigation 2000;106(8):1039-52.
1999: Jan M Prins; Suzanne Jurriaans; Rieneke van Praag; H Blaak; Ronald P van Rij; P T A Schellekens; Ineke J M ten Berge; Si-La Yong; C H Fox; Marijke Th L Roos; Frank de Wolf; Jaap Goudsmit; Hanneke Schuitemaker; Joep M A Lange
Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy.
AIDS (London, England) 1999;13(17):2405-10.
1999: Ana Maria de Roda Husman; Ronald P van Rij; H Blaak; SM Broersen; Hanneke Schuitemaker
Adaptation to promiscuous usage of chemokine receptors is not a prerequisite for human immunodeficiency virus type 1 disease progression.
The Journal of infectious diseases 1999;180(4):1106-15.
1999: Ronald P van Rij; Peter Portegies; T Hallaby; Joep M A Lange; J Visser; Ana Maria de Roda Husman; Angélique B van 't Wout; Hanneke Schuitemaker
Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
The Journal of infectious diseases 1999;180(3):854-7.
1999: Laurence Meyer; M Magierowska; Jean-Baptiste Hubert; Ioannis Theodorou; Ronald P van Rij; Maria Prins; Ana Maria de Roda Husman; Roel A Coutinho; Hanneke Schuitemaker
CC-chemokine receptor variants, SDF-1 polymorphism, and disease progression in 720 HIV-infected patients. SEROCO Cohort. Amsterdam Cohort Studies on AIDS.
AIDS (London, England) 1999;13(5):624-6.
1998: Ronald P van Rij; Ana Maria de Roda Husman; Mieke C Brouwer; Jaap Goudsmit; Roel A Coutinho; Hanneke Schuitemaker
Role of CCR2 genotype in the clinical course of syncytium-inducing (SI) or non-SI human immunodeficiency virus type 1 infection and in the time to conversion to SI virus variants.
The Journal of infectious diseases 1998;178(6):1806-11.
1998: Ronald P van Rij; SM Broersen; Jaap Goudsmit; Roel A Coutinho; Hanneke Schuitemaker
The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection.
AIDS (London, England) 1998;12(9):F85-90.